FDA Requests Device Info for Novel Parkinson Disease Infusion Therapy
ABBV-951 is a solution of levodopa and carbidopa prodrugs for continuous subcutaneous delivery.
Diagnosis & Disease Information
FDA Needs More Data Before Deciding on Apomorphine Infusion Device
SPN-830 provides a continuous subutaneous infusion of apomorphine through an infusion pump
Supernus One Step Closer to Decision on Apomorphine Infusion Device
SPN-830 provides a continuous subcutaneous infusion of apomorphine through an infusion pump.
Novel Pramipexole-Rasagiline Combo Promising for Early Parkinson Disease
The fixed-dose combination therapy was found to be superior to each component.
AAN Updates Recommendations for Early Parkinson Disease Treatment
Counseling should be provided to individuals with early Parkinson disease on the benefits and risks of initiating treatment.
Focused Ultrasound Device Approved for Advanced Parkinson Disease
Patients are awake and responsive during the whole treatment duration.
Continuous SC Infusion Therapy Bests Oral Levodopa/Carbidopa in Parkinson Trial
The randomized, double-blind, double-dummy, active-controlled study compared ABBV-951 via continuous SC infusion to oral levodopa/carbidopa.
Stem Cell Therapy Gets Fast Track Status for Parkinson Disease
DA01 is an investigational pluripotent stem cell-derived dopaminergic neuron therapy designed to replace the midbrian dopaminergic neurons lost in Parkinson disease.
- Loading...
Loading...
Next post in News
Loading... 
Loading...